He brings a wealth of legal and strategic expertise supporting global, pre-clinical and clinical development, manufacturing and commercializat PDUFA Target Action Date for ensifentrine of June 26 ...

Bruker provides a portfolio of preclinical imaging tools, including magnetic resonance imaging (MRI), positron emission tomography (PET), and single photon emission computed tomography (SPECT ...

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine ...

The expanding clinical initiatives aimed at broadening the utility of ensifentrine, such as trials in China and studies for new treatment combinations, indicate Verona Pharma’s commitment to ...

Secondly, the company’s strategic projects like Ensifentrine hold future potential for investors. It is a first-in-class dual inhibitor of PDE3 and PDE4, targeting inflammation and ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

Donald Trump has addressed supporters at a victory rally in Washington DC ahead of his inauguration on Monday He told a packed arena he plans to sign a host of executive orders on the first day of ...

For further information please contact: Verona P Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more than 2,200 unique ...

Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...

The major findings of this study of exacerbations of COPD can be summarised as follows: (a) among patients with elevated CRP, those receiving NAC were more likely to have this marker normalised ...